CALR and osteosarcoma: However, the presence of redox stress alone does not suffice to translocate calreticulin, as cisplatin treated osteosarcoma cells were unable to expose calreticulin, although significant levels of apoptosis, mitochondrial damage, and ATP release were induced (133).